Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christodoulos Papadopoulos

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Current Vascular Pharmacology|April 1, 2020
The Impact of Various Blood Pressure Measurements on Cardiovascular OutcomesConstantinos Bakogiannis, Konstantinos Stavropoulos, Christodoulos Papadopoulos, et al.
The American Journal of Cardiology|January 20, 2022
Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor AgonistsDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
Clinical Rheumatology|August 25, 2021
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trialsDimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos, et al.
Kardiologia Polska|July 22, 2021
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors?Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|December 23, 2025
Effects of Long-Term Use of Sodium-Glucose Co-Transporter-2 Inhibitors on Proteinuria and Renal Function in Patients with Type 2 Diabetes Mellitus without Chronic Kidney Disease during the COVID-19 PandemicDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
European Journal of Internal Medicine|December 1, 2021
Colchicine for the prevention of COVID-19 "hard" outcomes: All that glitters is not goldDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
Case Reports in Medicine|January 26, 2017
A Case of a Paracardial Osteophyte Causing Atrial CompressionStergios Tzikas, Konstantinos Triantafyllou, Christodoulos Papadopoulos, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 26, 2024
Accelerated idioventricular rhythm as a manifestation of chronic renocardiac syndrome: A case reportDimitrios Kotzadamis, Evangelia Gkroumtsia, Christodoulos Papadopoulos, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Minerva Cardiology and Angiology|July 26, 2024
Using ChatGPT to perform a systematic review: a tutorialLefteris Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Current Vascular Pharmacology|April 1, 2020
The Impact of Various Blood Pressure Measurements on Cardiovascular OutcomesConstantinos Bakogiannis, Konstantinos Stavropoulos, Christodoulos Papadopoulos, et al.
The American Journal of Cardiology|January 20, 2022
Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor AgonistsDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
Clinical Rheumatology|August 25, 2021
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trialsDimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos, et al.
Kardiologia Polska|July 22, 2021
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors?Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|December 23, 2025
Effects of Long-Term Use of Sodium-Glucose Co-Transporter-2 Inhibitors on Proteinuria and Renal Function in Patients with Type 2 Diabetes Mellitus without Chronic Kidney Disease during the COVID-19 PandemicDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
European Journal of Internal Medicine|December 1, 2021
Colchicine for the prevention of COVID-19 "hard" outcomes: All that glitters is not goldDimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, et al.
Case Reports in Medicine|January 26, 2017
A Case of a Paracardial Osteophyte Causing Atrial CompressionStergios Tzikas, Konstantinos Triantafyllou, Christodoulos Papadopoulos, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 26, 2024
Accelerated idioventricular rhythm as a manifestation of chronic renocardiac syndrome: A case reportDimitrios Kotzadamis, Evangelia Gkroumtsia, Christodoulos Papadopoulos, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, et al.
Minerva Cardiology and Angiology|July 26, 2024
Using ChatGPT to perform a systematic review: a tutorialLefteris Teperikidis, Aristi Boulmpou, Christodoulos Papadopoulos, et al.
Pageof 13